000 | 01723 a2200505 4500 | ||
---|---|---|---|
005 | 20250515055759.0 | ||
264 | 0 | _c20070307 | |
008 | 200703s 0 0 eng d | ||
022 | _a1530-7905 | ||
024 | 7 |
_a10.1385/ct:6:2:131 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Liansheng | |
245 | 0 | 0 |
_aManipulating glutathione-S-transferases may prevent the development of tolerance to nitroglycerin. _h[electronic resource] |
260 |
_bCardiovascular toxicology _c2006 |
||
300 |
_a131-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCyclic GMP _xphysiology |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aGlutathione Transferase _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMicroscopy, Confocal |
650 | 0 | 4 |
_aMuscle, Smooth _xcytology |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
650 | 0 | 4 |
_aNitroglycerin _xpharmacology |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aPeroxynitrous Acid _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
700 | 1 | _aYang, Yongzhen | |
700 | 1 | _aDwivedi, Seema | |
700 | 1 | _aXu, Ya | |
700 | 1 | _aChu, Etem T | |
700 | 1 | _aLi, Jie | |
700 | 1 | _aFitchett, Kimberlyn | |
700 | 1 | _aBoor, Paul J | |
773 | 0 |
_tCardiovascular toxicology _gvol. 6 _gno. 2 _gp. 131-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1385/ct:6:2:131 _zAvailable from publisher's website |
999 |
_c16863174 _d16863174 |